Aims and Scope

CVIR Endovascular is the multidisciplinary open access journal in the field of endovascular therapies. The journal publishes peer-reviewed papers on endovascular interventions and is intended for all specialists with an interest in vascular disease.

CVIR Endovascular publishes a wide range of manuscript types including original scientific papers, review articles, commentaries, technical reports, case reports and letters to the editor.

CVIR Endovascular welcomes submissions on arterial interventions, venous interventions, non-oncological embolization including trauma, aortic interventions, vascular malformations, and neuro interventions.

The field of endovascular treatment is dynamic, and new ideas need rapid communication so that the latest information is available to treat our patients. CVIR Endovascular provides an excellent podium to discuss your research work with your peers.

CVIR Endovascular is an official journal of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE). As part of the CIRSE journal family, it embodies the society’s dedication to promoting excellence in research and clinical practice, fostering innovation, and advancing patient care within the global vascular community.

Prof. Robert Morgan is a specialist Interventional and Diagnostic Radiologist with a major interest in the management of vascular disease.

He is a Consultant Radiologist at St George’s University Hospitals NHS Foundation Trust and is an Honorary Reader in Interventional Radiology at St George’s, University of London.

Prof. Morgan has over 30 years’ experience in diagnostic and interventional radiology. He has an international reputation in his specialist field of vascular disease. He can provide a very wide range of diagnostic imaging studies and interventional radiological procedures.

It is a great honour for me to take up the role of Editor-in-Chief of CVIR Endovascular in September 2025.

My aim is to further build on the success of the journal that has been achieved to date by Professor Jim Reekers, the editorial team at CVIR Endovascular, and you the authors of the many published manuscripts that have helped to attain the current Impact Factor of 1.5 - truly an impressive achievement given the journal’s launch in 2017.

Together we will go forward to build on the success to date, and to make CVIR Endovascular the go-to Open Access journal for endovascular specialists.     

Robert Morgan, CVIR Endovascular Editor-in-Chief